Variables | Cases (No.) (n = 93) | HSP90 | P | PUS7 | P | LASP1 | P | |||
---|---|---|---|---|---|---|---|---|---|---|
Low expression | High expression | Low expression | High expression | Low expression | High expression | |||||
Age (years) | Â | Â | Â | 0.562 | Â | Â | 0.780 | Â | Â | 0.210 |
<  60 | 34 | 9 | 25 |  | 16 | 18 |  | 16 | 18 |  |
≥ 60 | 59 | 19 | 40 |  | 26 | 33 |  | 20 | 39 |  |
Gender | Â | Â | Â | 0.128 | Â | Â | 0.533 | Â | Â | 0.218 |
Male | 52 | 19 | 33 | Â | 22 | 30 | Â | 23 | 29 | Â |
Female | 41 | 9 | 32 | Â | 20 | 21 | Â | 13 | 28 | Â |
Pathological stage | Â | Â | Â | 0.044 | Â | Â | 0.157 | Â | Â | 0.836 |
Stage I | 2 | 2 | 0 | Â | 2 | 0 | Â | 1 | 1 | Â |
Stage II | 73 | 23 | 50 | Â | 30 | 43 | Â | 29 | 44 | Â |
Stage III | 18 | 3 | 15 | Â | 10 | 8 | Â | 6 | 12 | Â |
Tumor size | Â | Â | Â | 0.528 | Â | Â | 0.499 | Â | Â | 0.042 |
<  5 cm | 48 | 16 | 32 |  | 23 | 25 |  | 23 | 25 |  |
≥ 5 cm | 44 | 12 | 32 |  | 18 | 26 |  | 12 | 32 |  |
T stage | Â | Â | Â | 0.034 | Â | Â | 0.030 | Â | Â | 0.005 |
T2 | 5 | 3 | 2 | Â | 4 | 1 | Â | 5 | 0 | Â |
T3 | 64 | 21 | 43 | Â | 30 | 34 | Â | 24 | 40 | Â |
T4 | 16 | 1 | 15 | Â | 3 | 13 | Â | 3 | 13 | Â |
N stage | Â | Â | Â | 0.032 | Â | Â | 0.249 | Â | Â | 0.093 |
N0 | 51 | 21 | 30 | Â | 22 | 29 | Â | 24 | 27 | Â |
N1 | 28 | 7 | 21 | Â | 15 | 13 | Â | 7 | 21 | Â |
N2 | 9 | 0 | 9 | Â | 2 | 7 | Â | 2 | 7 | Â |
Metastasis | Â | Â | Â | 0.18 | Â | Â | 0.408 | Â | Â | 0.104 |
0(no) | 89 | 28 | 61 | Â | 41 | 48 | Â | 36 | 53 | Â |
1(yes) | 4 | 0 | 4 | Â | 1 | 3 | Â | 0 | 4 | Â |
Clinical stage | Â | Â | Â | 0.034 | Â | Â | 0.547 | Â | Â | 0.008 |
Stage I | 4 | 3 | 1 | Â | 3 | 1 | Â | 4 | 0 | Â |
Stage II | 41 | 16 | 25 | Â | 18 | 23 | Â | 18 | 23 | Â |
Stage III | 35 | 7 | 28 | Â | 16 | 19 | Â | 9 | 26 | Â |
Stage IV | 4 | 0 | 4 | Â | 1 | 3 | Â | 0 | 4 | Â |